Literature DB >> 16586183

Prevalence and characteristics of chronic pain in veterans with spinal cord injury.

Diana H Rintala1, Sally Ann Holmes, Richard Neil Fiess, Daisy Courtade, Paul G Loubser.   

Abstract

To assess prevalence and characteristics of individual chronic (>6 mo) pain components in the veteran spinal cord injury (SCI) population, we conducted a telephone survey with 348 (66%) of 530 veterans with SCI who received care from one regional Department of Veterans Affairs SCI center during a 3 yr period. The short-form McGill Pain Questionnaire was used to assess qualitative properties of the pain experience. Other questions were used to assess frequency, duration, intensity, exacerbating factors, and effects on daily activities. Of the participants, 75% reported at least one chronic pain component. The majority (83%) of the chronic pain components occurred daily (mean = 27.4 d/mo) and lasted most of the day (mean = 17.4 h/d). Mean pain intensity in the week before the interview averaged 6.7 (on a 0 to 10 scale), while worst pain intensity averaged 8.6. Two-thirds (67%) of the chronic pain components interfered with daily activities. The most commonly selected pain descriptors were "aching," "sharp," "hot-burning," and "tiring-exhausting." More research is needed to identify better ways to prevent, assess, and treat chronic pain in the veteran SCI population.

Entities:  

Mesh:

Year:  2005        PMID: 16586183     DOI: 10.1682/jrrd.2005.02.0033

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  7 in total

1.  Cell cycle activation contributes to increased neuronal activity in the posterior thalamic nucleus and associated chronic hyperesthesia after rat spinal cord contusion.

Authors:  Junfang Wu; Charles Raver; Chunshu Piao; Asaf Keller; Alan I Faden
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

2.  Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  J Rehabil Res Dev       Date:  2009

3.  Pain among veterans with spinal cord injury.

Authors:  Philip M Ullrich; Mark P Jensen; John D Loeser; Diana D Cardenas; Frances M Weaver
Journal:  J Rehabil Res Dev       Date:  2008

4.  Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain.

Authors:  Aldric T Hama; James P Pearson; Jacqueline Sagen
Journal:  Pharmacol Res Perspect       Date:  2014-03-13

5.  Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.

Authors:  Zee-A Han; Dae Heon Song; Hyun-Mi Oh; Myung Eun Chung
Journal:  Ann Neurol       Date:  2016-02-16       Impact factor: 10.422

6.  Can Botulinum Toxin Type A effectively treat neuropathic pain in spinal cord injury?: A protocol of systematic review and meta-analysis.

Authors:  Zeng-Mian Wang; Ze-Yu Wang; Chun-Jie Wei; Yao-Jia Jiang
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

7.  Beyond the Diagnosis: Lived Experiences of Persons with Spinal Cord Injury in a Selected Town in Ghana.

Authors:  Abdul-Ganiyu Fuseini; Patience Aniteye; Afizu Alhassan
Journal:  Neurol Res Int       Date:  2019-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.